Roy Buchanan

Stock Analyst at JMP Securities

(0.92)
# 2,853
Out of 4,438 analysts
32
Total ratings
32.26%
Success rate
-22.81%
Average return

11 Stocks

Enanta Pharmaceuticals
May 7, 2024
Maintains: Market Outperform
Price Target: $23$22
Current: $12.47
Upside: +76.42%
Arbutus Biopharma
Apr 4, 2024
Reiterates: Market Outperform
Price Target: $4
Current: $3.21
Upside: +24.61%
Gritstone bio
Apr 2, 2024
Maintains: Market Outperform
Price Target: $4$5
Current: $0.83
Upside: +502.85%
AN2 Therapeutics
Apr 2, 2024
Upgrades: Market Outperform
Price Target: $6
Current: $2.17
Upside: +177.14%
Inovio Pharmaceuticals
Jan 4, 2024
Initiates: Market Outperform
Price Target: $12
Current: $10.99
Upside: +9.19%
Dynavax Technologies
Nov 3, 2023
Maintains: Market Outperform
Price Target: $25$27
Current: $11.46
Upside: +135.60%
CureVac
Apr 26, 2023
Maintains: Outperform
Price Target: $34$24
Current: $3.29
Upside: +629.48%
Esperion Therapeutics
Mar 6, 2023
Reiterates: Market Outperform
Price Target: $15
Current: $2.41
Upside: +522.41%
argenx SE
Mar 3, 2023
Maintains: Market Outperform
Price Target: $443$448
Current: $356.66
Upside: +25.61%
CorMedix
Mar 1, 2023
Maintains: Market Perform
Price Target: $14$16
Current: $5.08
Upside: +214.96%
iBio, Inc.
Feb 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $2.33
Upside: -